Drug Profile


Alternative Names: B 78820; BY 820

Latest Information Update: 24 Jun 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ALTANA Pharma
  • Class Aniline compounds; Nonsteroidal anti-inflammatories; Small molecules; Thiophenes
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation; Osteoarthritis

Most Recent Events

  • 24 Jun 2002 Discontinued - Clinical-Phase-Unknown for Osteoarthritis in Finland (Topical)
  • 24 Jun 2002 Discontinued - Clinical-Phase-Unknown for Osteoarthritis in Sweden (Topical)
  • 24 Jun 2002 Discontinued - Phase-I for Inflammation in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top